{"id":"W4387358615","doi":"10.1016/j.conctc.2023.101211","title":"INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion","year":2023,"lang":"en","type":"article","venue":"Contemporary Clinical Trials Communications","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Sucampo Pharmaceuticals","keywords":"Terlipressin; Medicine; Hepatorenal syndrome; Liver transplantation; Liver disease; Acute kidney injury; Bolus (digestion); Midodrine; Population; Kidney disease; Transplantation; Hemodialysis; Intensive care medicine; Internal medicine; Cirrhosis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08900063,0.003213434,0.003848681,0.00160225,0.00312153,0.00281927,0.003451023,0.003702112,0.005677962],"category_scores_gemma":[0.05275696,0.001812737,0.002522672,0.001392363,0.004451069,0.002405934,0.003584757,0.003186399,0.001765307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001618077,"about_ca_system_score_gemma":0.008457267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008788828,"about_ca_topic_score_gemma":0.00176127,"domain_scores_codex":[0.9283151,0.05711213,0.003626826,0.003934523,0.005125845,0.001885582],"domain_scores_gemma":[0.9703766,0.008857407,0.004953079,0.006045344,0.004027491,0.005740097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7058762,0.06287555,0.09661566,0.004752518,0.005154213,0.001168043,0.003551082,0.004383804,0.01062009,0.02427714,0.01091673,0.06980897],"study_design_scores_gemma":[0.5651464,0.2961885,0.04814528,0.002101561,0.004078994,0.0008832853,0.001137494,0.01268754,0.004776519,0.01036749,0.05408567,0.0004012843],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.1682008,0.002577681,0.03445707,0.004210168,0.001985124,0.7768594,0.00390632,0.0001850702,0.007618403],"genre_scores_gemma":[0.2348558,0.0007449798,0.06681786,0.004384281,0.001688619,0.6886053,0.001419898,0.00004282437,0.001440423],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.08900063,"threshold_uncertainty_score":0.470686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5833599997132853,"score_gpt":0.530393035223922,"score_spread":0.05296696448936333,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}